Direct oral anticoagulants in older patients with atrial fibrillation and comorbidities: frailty, renal impairment, acute or chronic coronary syndromes, and acute stroke

医学 达比加群 心房颤动 急性冠脉综合征 内科学 心脏病学 禁忌症 阿哌沙班 拜瑞妥 氯吡格雷 华法林 冲程(发动机) 经皮冠状动脉介入治疗 传统PCI 颅内出血 直接凝血酶抑制剂 重症监护医学 临床试验 心肌梗塞 经皮 肾功能 血小板聚集抑制剂 急性肾损伤
作者
Felicita Andreotti,Adhithya N. Balaji,Luigi Cappannoli,Lidia Megaro,Francesco Landi,Francesco Burzotta
出处
期刊:Polskie Archiwum Medycyny Wewnetrznej-polish Archives of Internal Medicine [Medycyna Praktyczna]
卷期号:136 (7-8) 被引量:2
标识
DOI:10.20452/pamw.17319
摘要

Direct oral anticoagulants (DOACs) have been available since 2008, boosting appropriate anticoagulation and reducing intracranial hemorrhages, as compared with warfarin therapy. However, for older individuals with atrial fibrillation (AF) and comorbidities, decisions on DOAC therapy may be challenging. In frail, stable‑on‑warfarin patients, the FRAIL‑AF (Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation) trial reported increased relevant bleeding after switching to a DOAC. Subsequent individual patient‑data analyses of 4 pivotal DOAC‑vs‑warfarin AF trials confirmed the overall advantages of DOACs over warfarin even among older, frail, warfarin‑experienced individuals. Advanced age should not exclude the use of any DOAC for AF, but care is needed to adjust the doses, when indicated, particularly based on renal function. All DOACs undergo variable renal clearance and, in Europe, creatinine clearance below 30 ml/min contraindicates dabigatran, and below 15 ml/min factor‑Xa inhibitors. AF patients on DOACs presenting with acute coronary syndrome and / or requiring percutaneous coronary interventions are generally managed with additional dual antiplatelet therapy for 1-4 weeks, followed by clopidogrel plus DOAC for up to 1 year. AF patients with chronic coronary syndromes should generally receive a DOAC without additional antiplatelet therapy, as this abates major bleeding and improves cardiovascular survival without evidence of increased ischemic risk. For AF patients who develop acute ischemic stroke, recent exposure to a DOAC is a relative contraindication to intravenous thrombolysis, but the latter may be considered when clinically‑relevant anticoagulation can be excluded. Finally, for AF patients who develop nonsevere hemorrhagic stroke during DOAC therapy, resuming a DOAC to prevent ischemic strokes is counterbalanced by considerably enhanced major bleeding, including intracranial.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小王发布了新的文献求助10
刚刚
鸭梨发布了新的文献求助10
刚刚
yhuyfuhk完成签到 ,获得积分10
刚刚
呆萌发布了新的文献求助10
刚刚
田様的应助被Mxr采纳,获得10
1秒前
1秒前
董亦菲发布了新的文献求助10
1秒前
猫好好发布了新的文献求助10
1秒前
1秒前
1秒前
2秒前
Jevon完成签到 ,获得积分10
2秒前
2秒前
qiu发布了新的文献求助10
2秒前
2秒前
zisezhaoyan发布了新的文献求助10
2秒前
2秒前
华仔的应助被hhh采纳,获得10
3秒前
3秒前
汉堡包的应助被wsw111采纳,获得10
4秒前
4秒前
4秒前
呆萌完成签到,获得积分10
5秒前
搬砖ing完成签到,获得积分10
5秒前
molihuakai的应助被Lu采纳,获得10
5秒前
无极微光的应助被Shu采纳,获得30
5秒前
Amani_Nakupenda完成签到,获得积分10
5秒前
5秒前
6秒前
hahaha625的应助被古德采纳,获得10
6秒前
标致青雪发布了新的文献求助10
6秒前
lytelope完成签到,获得积分10
6秒前
6秒前
ZJH发布了新的文献求助10
7秒前
汉堡包的应助被杰里西采纳,获得10
7秒前
熊猫海发布了新的文献求助50
7秒前
7秒前
沙沙发布了新的文献求助10
7秒前
隐形曼青的应助被景麟采纳,获得10
7秒前
桐桐的应助被Stephen采纳,获得10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183091
求助须知:如何正确求助?哪些是违规求助? 9572406
关于积分的说明 21825003
捐赠科研通 7779812
什么是DOI,文献DOI怎么找? 3433837
关于科研通互助平台的介绍 2558045
邀请新用户注册赠送积分活动 2480046